{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T07:18:14Z","timestamp":1787987894084,"version":"build-2784847793"},"reference-count":118,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T00:00:00Z","timestamp":1787961600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T00:00:00Z","timestamp":1787961600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"\u201cClinical Technology Innovation Project\u201d of Shanghai Hospital Development Center","award":["SHDC12023103"],"award-info":[{"award-number":["SHDC12023103"]}]},{"name":"\u201cGuhai Plan in the 14th Five-Year Plan Period\u201d of the First Affiliated Hospital of Naval Medical University","award":["GH145-22 and GH145XKQ-03"],"award-info":[{"award-number":["GH145-22 and GH145XKQ-03"]}]},{"name":"\u201cAdvanced and Appropriate Technology Popularization Project\u201d of Shanghai Municipal Health Commission","award":["No. 2019SY029"],"award-info":[{"award-number":["No. 2019SY029"]}]},{"name":"\u201cMajor Research Plan\u201d of the National Natural Science Foundation of China","award":["92359204"],"award-info":[{"award-number":["92359204"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Jpn J Radiol"],"DOI":"10.1007\/s11604-026-02066-7","type":"journal-article","created":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T06:21:23Z","timestamp":1787984483000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Emerging frontiers and challenges of artificial intelligence in PSMA-PET imaging: pioneering a new chapter in prostate cancer care"],"prefix":"10.1007","author":[{"given":"Yiting","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingsheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changjing","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,29]]},"reference":[{"key":"2066_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2022","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2022;74:229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"key":"2066_CR2","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.2967\/jnumed.117.191031","volume":"58","author":"SM Schwarzenboeck","year":"2017","unstructured":"Schwarzenboeck SM, Rauscher I, Bluemel C, Fendler WP, Rowe SP, Pomper MG, et al. PSMA ligands for PET imaging of prostate cancer. J Nucl Med. 2017;58:1545\u201352. https:\/\/doi.org\/10.2967\/jnumed.117.191031.","journal-title":"J Nucl Med"},{"key":"2066_CR3","doi-asserted-by":"publisher","first-page":"596","DOI":"10.2967\/jnumed.120.257238","volume":"62","author":"A Farolfi","year":"2021","unstructured":"Farolfi A, Calderoni L, Mattana F, Mei R, Telo S, Fanti S, et al. Current and emerging clinical applications of PSMA PET diagnostic imaging for prostate cancer. J Nucl Med. 2021;62:596\u2013604. https:\/\/doi.org\/10.2967\/jnumed.120.257238.","journal-title":"J Nucl Med"},{"key":"2066_CR4","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.eururo.2023.03.001","volume":"84","author":"KM Chow","year":"2023","unstructured":"Chow KM, So WZ, Lee HJ, Lee A, Yap DWT, Takwoingi Y, et al. Head-to-head comparison of the diagnostic accuracy of prostate-specific membrane antigen positron emission tomography and conventional imaging modalities for initial staging of intermediate- to high-risk prostate cancer: a systematic review and meta-analysis. Eur Urol. 2023;84:36\u201348. https:\/\/doi.org\/10.1016\/j.eururo.2023.03.001.","journal-title":"Eur Urol"},{"key":"2066_CR5","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41391-018-0048-7","volume":"21","author":"I Berger","year":"2018","unstructured":"Berger I, Annabattula C, Lewis J, Shetty DV, Kam J, Maclean F, et al. 68Ga-PSMA PET\/CT vs. mpMRI for locoregional prostate cancer staging: correlation with final histopathology. Prostate Cancer Prostatic Dis. 2018;21:204\u201311. https:\/\/doi.org\/10.1038\/s41391-018-0048-7.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"2066_CR6","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1007\/s00259-024-06594-0","volume":"51","author":"ML Donswijk","year":"2024","unstructured":"Donswijk ML, Ettema RH, Meijer D, Wondergem M, Cheung Z, Bekers EM, et al. The accuracy and intra- and interobserver variability of PSMA PET\/CT for the local staging of primary prostate cancer. Eur J Nucl Med Mol Imaging. 2024;51:1741\u201352. https:\/\/doi.org\/10.1007\/s00259-024-06594-0.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2066_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s12880-025-01557-9","volume":"25","author":"L Ma","year":"2025","unstructured":"Ma L, Hao Y, Zhai L, Zhang W, Cao X, Jia K. Which PSMA PET\/CT interpretation criteria most effectively diagnose prostate cancer? A retrospective cohort study. BMC Med Imaging. 2025;25:23. https:\/\/doi.org\/10.1186\/s12880-025-01557-9.","journal-title":"BMC Med Imaging"},{"key":"2066_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-021-00497-2","volume":"4","author":"AS Chaudhari","year":"2021","unstructured":"Chaudhari AS, Mittra E, Davidzon GA, Gulaka P, Gandhi H, Brown A, et al. Low-count whole-body PET with deep learning in a multicenter and externally validated study. NPJ Digit Med. 2021;4:127. https:\/\/doi.org\/10.1038\/s41746-021-00497-2.","journal-title":"NPJ Digit Med"},{"key":"2066_CR9","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s12149-021-01710-8","volume":"36","author":"K Matsubara","year":"2022","unstructured":"Matsubara K, Ibaraki M, Nemoto M, Watabe H, Kimura Y. A review on AI in PET imaging. Ann Nucl Med. 2022;36:133\u201343. https:\/\/doi.org\/10.1007\/s12149-021-01710-8.","journal-title":"Ann Nucl Med"},{"key":"2066_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2024.109339","volume":"184","author":"FE \u00d6\u011f\u00fclm\u00fc\u015f","year":"2025","unstructured":"\u00d6\u011f\u00fclm\u00fc\u015f FE, Almal\u0131o\u011flu Y, Tamam M\u00d6, Y\u0131ld\u0131r\u0131m B, Uysal E, Numano\u011flu \u00c7, et al. Integrating PET\/CT, radiomics and clinical data: an advanced multi-modal approach for lymph node metastasis prediction in prostate cancer. Comput Biol Med. 2025;184:109339. https:\/\/doi.org\/10.1016\/j.compbiomed.2024.109339.","journal-title":"Comput Biol Med"},{"key":"2066_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12880-025-01571-x","volume":"25","author":"TO Alkahtani","year":"2025","unstructured":"Alkahtani TO. Investigating the significance of SPECT\/CT-SUV for monitoring 177Lu-PSMA-targeted radionuclide therapy: a systematic review. BMC Med Imaging. 2025;25:28. https:\/\/doi.org\/10.1186\/s12880-025-01571-x.","journal-title":"BMC Med Imaging"},{"key":"2066_CR12","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41585-024-00900-z","volume":"22","author":"MK Bakht","year":"2025","unstructured":"Bakht MK, Beltran H. Biological determinants of PSMA expression, regulation and heterogeneity in prostate cancer. Nat Rev Urol. 2025;22:26\u201345. https:\/\/doi.org\/10.1038\/s41585-024-00900-z.","journal-title":"Nat Rev Urol"},{"key":"2066_CR13","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/s41391-022-00534-5","volume":"25","author":"A Tian","year":"2022","unstructured":"Tian A, Lin R, Yu J, Zhang F, Zheng Q, Yuan X, et al. The differential diagnostic value of dual-phase 18F-DCFPyL PET\/CT in prostate carcinoma. Prostate Cancer Prostatic Dis. 2022;25:351\u20138. https:\/\/doi.org\/10.1038\/s41391-022-00534-5.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"2066_CR14","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s00259-015-3188-1","volume":"43","author":"F Sterzing","year":"2016","unstructured":"Sterzing F, Kratochwil C, Fiedler H, Katayama S, Habl G, Kopka K, et al. 68Ga-PSMA-11 PET\/CT: a new technique with high potential for the radiotherapeutic management of prostate cancer patients. Eur J Nucl Med Mol Imaging. 2016;43:34\u201341. https:\/\/doi.org\/10.1007\/s00259-015-3188-1.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2066_CR15","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.1158\/1078-0432.CCR-19-1485","volume":"26","author":"K Current","year":"2020","unstructured":"Current K, Meyer C, Magyar CE, Mona CE, Almajano J, Slavik R, et al. Investigating PSMA-targeted radioligand therapy efficacy as a function of cellular PSMA levels and intratumoral PSMA heterogeneity. Clin Cancer Res. 2020;26:2946\u201355. https:\/\/doi.org\/10.1158\/1078-0432.CCR-19-1485.","journal-title":"Clin Cancer Res"},{"key":"2066_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2024.09.020","author":"Y-H Dai","year":"2024","unstructured":"Dai Y-H, Chen P-H, Lee D-J, Andrade G, Vallis KA. A meta-analysis and meta-regression of the efficacy, toxicity, and quality of life outcomes following prostate-specific membrane antigen radioligand therapy utilising Lutetium-177 and Actinium-225 in metastatic prostate cancer. Eur Urol. 2024. https:\/\/doi.org\/10.1016\/j.eururo.2024.09.020.","journal-title":"Eur Urol"},{"key":"2066_CR17","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1159\/000515651","volume":"106","author":"D Kopp","year":"2022","unstructured":"Kopp D, Kopp J, Bernhardt E, Manka L, Beck A, Gerullis H, et al. 68Ga-prostate-specific membrane antigen positron emission tomography-computed tomography-based primary staging and histological correlation after extended pelvic lymph node dissection in intermediate-risk prostate cancer. Urol Int. 2022;106:56\u201362. https:\/\/doi.org\/10.1159\/000515651.","journal-title":"Urol Int"},{"key":"2066_CR18","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.eururo.2024.01.012","volume":"86","author":"WR Armstrong","year":"2024","unstructured":"Armstrong WR, Kishan AU, Booker KM, Grogan TR, Elashoff D, Lam EC, et al. Impact of prostate-specific membrane antigen positron emission tomography\/computed tomography on prostate cancer salvage radiotherapy management: results from a prospective multicenter randomized phase 3 trial (PSMA-SRT NCT03582774). Eur Urol. 2024;86:52\u201360. https:\/\/doi.org\/10.1016\/j.eururo.2024.01.012.","journal-title":"Eur Urol"},{"key":"2066_CR19","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.euo.2022.04.006","volume":"5","author":"T Kawada","year":"2022","unstructured":"Kawada T, Yanagisawa T, Rajwa P, Sari Motlagh R, Mostafaei H, Quhal F, et al. Diagnostic performance of prostate-specific membrane antigen positron emission tomography-targeted biopsy for detection of clinically significant prostate cancer: a systematic review and meta-analysis. Eur Urol Oncol. 2022;5:390\u2013400. https:\/\/doi.org\/10.1016\/j.euo.2022.04.006.","journal-title":"Eur Urol Oncol"},{"key":"2066_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-025-07076-7","author":"M Wenzel","year":"2025","unstructured":"Wenzel M, Hoeh B, Siech C, Koll F, Humke C, Groener D, et al. Lutetium-177 PSMA radioligand therapy in taxan-naive first- and second-line metastatic castration resistant prostate cancer after first-line ARPI therapy. Eur J Nucl Med Mol Imaging. 2025. https:\/\/doi.org\/10.1007\/s00259-025-07076-7.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2066_CR21","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1016\/S1470-2045(24)00326-7","volume":"25","author":"MJ Karpinski","year":"2024","unstructured":"Karpinski MJ, H\u00fcsing J, Claassen K, M\u00f6ller L, Kaj\u00fcter H, Oesterling F, et al. Combining PSMA-PET and PROMISE to re-define disease stage and risk in patients with prostate cancer: a multicentre retrospective study. Lancet Oncol. 2024;25:1188\u2013201. https:\/\/doi.org\/10.1016\/S1470-2045(24)00326-7.","journal-title":"Lancet Oncol"},{"key":"2066_CR22","doi-asserted-by":"publisher","first-page":"488","DOI":"10.2967\/jnumed.118.222893","volume":"61","author":"ME Mayerhoefer","year":"2020","unstructured":"Mayerhoefer ME, Materka A, Langs G, H\u00e4ggstr\u00f6m I, Szczypi\u0144ski P, Gibbs P, et al. Introduction to radiomics. J Nucl Med. 2020;61:488\u201395. https:\/\/doi.org\/10.2967\/jnumed.118.222893.","journal-title":"J Nucl Med"},{"key":"2066_CR23","doi-asserted-by":"publisher","first-page":"29S","DOI":"10.2967\/jnumed.118.220590","volume":"60","author":"F Nensa","year":"2019","unstructured":"Nensa F, Demircioglu A, Rischpler C. Artificial intelligence in nuclear medicine. J Nucl Med. 2019;60:29S-37S. https:\/\/doi.org\/10.2967\/jnumed.118.220590.","journal-title":"J Nucl Med"},{"key":"2066_CR24","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1007\/s00259-024-07060-7","volume":"52","author":"D Kersting","year":"2025","unstructured":"Kersting D, Borys K, K\u00fcper A, Kim M, Haubold J, Goerttler T, et al. Staging of prostate cancer with ultra-fast PSMA-PET scans enhanced by AI. Eur J Nucl Med Mol Imaging. 2025;52:1658\u201370. https:\/\/doi.org\/10.1007\/s00259-024-07060-7.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2066_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-024-02491-w","volume":"19","author":"JC Holzschuh","year":"2024","unstructured":"Holzschuh JC, Mix M, Freitag MT, H\u00f6lscher T, Braune A, Kotzerke J, et al. The impact of multicentric datasets for the automated tumor delineation in primary prostate cancer using convolutional neural networks on 18F-PSMA-1007 PET. Radiat Oncol. 2024;19:106. https:\/\/doi.org\/10.1186\/s13014-024-02491-w.","journal-title":"Radiat Oncol"},{"key":"2066_CR26","doi-asserted-by":"publisher","first-page":"4570","DOI":"10.7150\/thno.96921","volume":"14","author":"J Ning","year":"2024","unstructured":"Ning J, Spielvogel CP, Haberl D, Trachtova K, Stoiber S, Rasul S, et al. A novel assessment of whole-mount Gleason grading in prostate cancer to identify candidates for radical prostatectomy: a machine learning-based multiomics study. Theranostics Ivyspring Int Pub. 2024;14:4570\u201381. https:\/\/doi.org\/10.7150\/thno.96921.","journal-title":"Theranostics Ivyspring Int Pub"},{"key":"2066_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2024.110443","volume":"199","author":"Y Cao","year":"2024","unstructured":"Cao Y, Sutera P, Silva Mendes W, Yousefi B, Hrinivich T, Deek M, et al. Machine learning predicts conventional imaging metastasis-free survival (MFS) for oligometastatic castration-sensitive prostate cancer (omCSPC) using prostate-specific membrane antigen (PSMA) PET radiomics. Radiother Oncol. 2024;199:110443. https:\/\/doi.org\/10.1016\/j.radonc.2024.110443.","journal-title":"Radiother Oncol"},{"key":"2066_CR28","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.semcancer.2023.03.005","volume":"91","author":"J Dai","year":"2023","unstructured":"Dai J, Wang H, Xu Y, Chen X, Tian R. Clinical application of AI-based PET images in oncological patients. Semin Cancer Biol. 2023;91:124\u201342. https:\/\/doi.org\/10.1016\/j.semcancer.2023.03.005.","journal-title":"Semin Cancer Biol"},{"key":"2066_CR29","doi-asserted-by":"publisher","first-page":"2792","DOI":"10.21037\/qims-20-1078","volume":"11","author":"Z Cheng","year":"2021","unstructured":"Cheng Z, Wen J, Huang G, Yan J. Applications of artificial intelligence in nuclear medicine image generation. Quant Imaging Med Surg. 2021;11:2792\u2013822. https:\/\/doi.org\/10.21037\/qims-20-1078.","journal-title":"Quant Imaging Med Surg"},{"key":"2066_CR30","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s00259-023-06418-7","volume":"51","author":"I Shiri","year":"2023","unstructured":"Shiri I, Salimi Y, Maghsudi M, Jenabi E, Harsini S, Razeghi B, et al. Differential privacy preserved federated transfer learning for multi-institutional 68Ga-PET image artefact detection and disentanglement. Eur J Nucl Med Mol Imaging. 2023;51:40\u201353. https:\/\/doi.org\/10.1007\/s00259-023-06418-7.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2066_CR31","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1007\/s00259-024-07032-x","volume":"52","author":"AH Dias","year":"2025","unstructured":"Dias AH, Schaefferkoetter J, Madsen JR, Barkholt T\u00d8, Vendelbo MH, Rodell AB, et al. Validation and clinical impact of motion-free PET imaging using data-driven respiratory gating and elastic PET-CT registration. Eur J Nucl Med Mol Imaging. 2025;52:1924\u201336. https:\/\/doi.org\/10.1007\/s00259-024-07032-x.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2066_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.818329","volume":"11","author":"F Deng","year":"2021","unstructured":"Deng F, Li X, Yang F, Sun H, Yuan J, He Q, et al. Low-dose 68 Ga-PSMA prostate PET\/MRI imaging using deep learning based on MRI priors. Front Oncol. 2021;11:818329. https:\/\/doi.org\/10.3389\/fonc.2021.818329.","journal-title":"Front Oncol"},{"key":"2066_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s40658-024-00698-0","volume":"11","author":"Q Yang","year":"2024","unstructured":"Yang Q, Li W, Huang Z, Chen Z, Zhao W, Gao Y, et al. Bidirectional dynamic frame prediction network for total-body [68Ga]Ga-PSMA-11 and [68Ga]Ga-FAPI-04 PET images. EJNMMI Phys. 2024;11:92. https:\/\/doi.org\/10.1186\/s40658-024-00698-0.","journal-title":"EJNMMI Phys"},{"key":"2066_CR34","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s00259-020-04816-9","volume":"48","author":"A Pozaruk","year":"2021","unstructured":"Pozaruk A, Pawar K, Li S, Carey A, Cheng J, Sudarshan VP, et al. Augmented deep learning model for improved quantitative accuracy of MR-based PET attenuation correction in PSMA PET-MRI prostate imaging. Eur J Nucl Med Mol Imaging. 2021;48:9\u201320. https:\/\/doi.org\/10.1007\/s00259-020-04816-9.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2066_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1220009","volume":"13","author":"BS Abrahamsen","year":"2023","unstructured":"Abrahamsen BS, Knudtsen IS, Eikenes L, Bathen TF, Elschot M. Pelvic PET\/MR attenuation correction in the image space using deep learning. Front Oncol. 2023;13:1220009. https:\/\/doi.org\/10.3389\/fonc.2023.1220009.","journal-title":"Front Oncol"},{"key":"2066_CR36","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1097\/MNM.0000000000001891","volume":"45","author":"M Dorri Giv","year":"2024","unstructured":"Dorri Giv M, Arabi H, Naseri S, Alipour Firouzabad L, Aghaei A, Askari E, et al. Evaluation of the prostate cancer and its metastases in the [68Ga]Ga-PSMA PET\/CT images: deep learning method vs. conventional PET\/CT processing. Nucl Med Commun. 2024;45:974\u201383. https:\/\/doi.org\/10.1097\/MNM.0000000000001891.","journal-title":"Nucl Med Commun"},{"key":"2066_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s13550-023-00999-y","volume":"13","author":"C Margail","year":"2023","unstructured":"Margail C, Merlin C, Billoux T, Wallaert M, Otman H, Sas N, et al. Imaging quality of an artificial intelligence denoising algorithm: validation in 68Ga PSMA-11 PET for patients with biochemical recurrence of prostate cancer. EJNMMI Res. 2023;13:50. https:\/\/doi.org\/10.1186\/s13550-023-00999-y.","journal-title":"EJNMMI Res"},{"key":"2066_CR38","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1007\/s00259-025-07120-6","volume":"52","author":"B Laurent","year":"2025","unstructured":"Laurent B, Bousse A, Merlin T, Rominger A, Shi K, Visvikis D. Evaluation of deep learning-based scatter correction on a long-axial field-of-view PET scanner. Eur J Nucl Med Mol Imaging. 2025;52:2563\u201376. https:\/\/doi.org\/10.1007\/s00259-025-07120-6.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2066_CR39","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-025-07119-z","author":"A Mehranian","year":"2025","unstructured":"Mehranian A, Wollenweber SD, Bradley KM, Fielding PA, Huellner M, Iagaru A, et al. Deep learning-based time-of-flight (ToF) enhancement of non-ToF PET scans for different radiotracers. Eur J Nucl Med Mol Imaging. 2025. https:\/\/doi.org\/10.1007\/s00259-025-07119-z.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2066_CR40","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1007\/s00259-021-05631-6","volume":"49","author":"Z Yi","year":"2022","unstructured":"Yi Z, Hu S, Lin X, Zou Q, Zou M, Zhang Z, et al. Machine learning-based prediction of invisible intraprostatic prostate cancer lesions on 68 Ga-PSMA-11 PET\/CT in patients with primary prostate cancer. Eur J Nucl Med Mol Imaging. 2022;49:1523\u201334. https:\/\/doi.org\/10.1007\/s00259-021-05631-6.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2066_CR41","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1007\/s00259-021-05497-8","volume":"49","author":"K Johnsson","year":"2022","unstructured":"Johnsson K, Brynolfsson J, Sahlstedt H, Nickols NG, Rettig M, Probst S, et al. Analytical performance of aPROMISE: automated anatomic contextualization, detection, and quantification of [18F]DCFPyL (PSMA) imaging for standardized reporting. Eur J Nucl Med Mol Imaging. 2022;49:1041\u201351. https:\/\/doi.org\/10.1007\/s00259-021-05497-8.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2066_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11020186","volume":"11","author":"S Moazemi","year":"2021","unstructured":"Moazemi S, Erle A, L\u00fctje S, Gaertner FC, Essler M, Bundschuh RA. Estimating the potential of radiomics features and radiomics signature from pretherapeutic PSMA-PET-CT scans and clinical data for prediction of overall survival when treated with 177Lu-PSMA. Diagnostics (Basel). 2021;11:186. https:\/\/doi.org\/10.3390\/diagnostics11020186.","journal-title":"Diagnostics (Basel)"},{"key":"2066_CR43","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s11547-024-01820-z","volume":"129","author":"R Laudicella","year":"2024","unstructured":"Laudicella R, Comelli A, Schwyzer M, Stefano A, Konukoglu E, Messerli M, et al. PSMA-positive prostatic volume prediction with deep learning based on T2-weighted MRI. Radiol Med. 2024;129:901\u201311. https:\/\/doi.org\/10.1007\/s11547-024-01820-z.","journal-title":"Radiol Med"},{"key":"2066_CR44","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1007\/s00259-025-07113-5","volume":"52","author":"Y Lin","year":"2025","unstructured":"Lin Y, Wang K, Zheng Z, Yu H, Chen S, Tang W, et al. Eliminating the second CT scan of dual-tracer total-body PET\/CT via deep learning-based image synthesis and registration. Eur J Nucl Med Mol Imaging. 2025;52:2589\u2013604. https:\/\/doi.org\/10.1007\/s00259-025-07113-5.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2066_CR45","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.radonc.2019.07.005","volume":"141","author":"AS Bettermann","year":"2019","unstructured":"Bettermann AS, Zamboglou C, Kiefer S, Jilg CA, Spohn S, Kranz-Rudolph J, et al. [68Ga-]PSMA-11 PET\/CT and multiparametric MRI for gross tumor volume delineation in a slice by slice analysis with whole mount histopathology as a reference standard - implications for focal radiotherapy planning in primary prostate cancer. Radiother Oncol. 2019;141:214\u20139. https:\/\/doi.org\/10.1016\/j.radonc.2019.07.005.","journal-title":"Radiother Oncol"},{"key":"2066_CR46","doi-asserted-by":"publisher","first-page":"823","DOI":"10.2967\/jnumed.120.254623","volume":"62","author":"D Kostyszyn","year":"2021","unstructured":"Kostyszyn D, Fechter T, Bartl N, Grosu AL, Gratzke C, Sigle A, et al. Intraprostatic tumor segmentation on PSMA PET images in patients with primary prostate cancer with a convolutional neural network. journal of nuclear medicine. Soc Nuclear Med. 2021;62:823\u20138. https:\/\/doi.org\/10.2967\/jnumed.120.254623.","journal-title":"Soc Nuclear Med"},{"key":"2066_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2023.109774","volume":"188","author":"JC Holzschuh","year":"2023","unstructured":"Holzschuh JC, Mix M, Ruf J, H\u00f6lscher T, Kotzerke J, Vrachimis A, et al. Deep learning based automated delineation of the intraprostatic gross tumour volume in PSMA-PET for patients with primary prostate cancer. Radiother Oncol. 2023;188:109774. https:\/\/doi.org\/10.1016\/j.radonc.2023.109774.","journal-title":"Radiother Oncol"},{"key":"2066_CR48","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.eururo.2015.12.053","volume":"70","author":"M Eiber","year":"2016","unstructured":"Eiber M, Weirich G, Holzapfel K, Souvatzoglou M, Haller B, Rauscher I, et al. Simultaneous 68Ga-PSMA HBED-CC PET\/MRI improves the localization of primary prostate cancer. Eur Urol. 2016;70:829\u201336. https:\/\/doi.org\/10.1016\/j.eururo.2015.12.053.","journal-title":"Eur Urol"},{"key":"2066_CR49","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1007\/s00259-020-05111-3","volume":"48","author":"C Zamboglou","year":"2021","unstructured":"Zamboglou C, Bettermann AS, Gratzke C, Mix M, Ruf J, Kiefer S, et al. Uncovering the invisible\u2014prevalence, characteristics, and radiomics feature\u2013based detection of visually undetectable intraprostatic tumor lesions in 68GaPSMA-11 PET images of patients with primary prostate cancer. Eur J Nucl Med Mol Imaging. 2021;48:1987\u201397. https:\/\/doi.org\/10.1007\/s00259-020-05111-3.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2066_CR50","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s00259-019-04606-y","volume":"47","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, Gafita A, Vollnberg B, Tetteh G, Haupt F, Afshar-Oromieh A, et al. Deep neural network for automatic characterization of lesions on 68Ga-PSMA-11 PET\/CT. Eur J Nucl Med Mol Imaging. 2020;47:603\u201313. https:\/\/doi.org\/10.1007\/s00259-019-04606-y.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2066_CR51","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.2967\/jnumed.120.242057","volume":"61","author":"R Seifert","year":"2020","unstructured":"Seifert R, Herrmann K, Kleesiek J, Sch\u00e4fers M, Shah V, Xu Z, et al. Semiautomatically quantified tumor volume using 68Ga-PSMA-11 PET as a biomarker for survival in patients with advanced prostate cancer. J Nucl Med. 2020;61:1786\u201392. https:\/\/doi.org\/10.2967\/jnumed.120.242057.","journal-title":"J Nucl Med"},{"key":"2066_CR52","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1007\/s00259-023-06551-3","volume":"51","author":"B Huang","year":"2024","unstructured":"Huang B, Yang Q, Li X, Wu Y, Liu Z, Pan Z, et al. Deep learning\u2013based whole-body characterization of prostate cancer lesions on [68Ga]Ga-PSMA-11 PET\/CT in patients with post-prostatectomy recurrence. Eur J Nucl Med Mol Imaging. 2024;51:1173\u201384. https:\/\/doi.org\/10.1007\/s00259-023-06551-3.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2066_CR53","doi-asserted-by":"publisher","first-page":"795","DOI":"10.2967\/jnumed.124.269067","volume":"66","author":"CS Constantino","year":"2025","unstructured":"Constantino CS, Oliveira FPM, Machado M, Vinga S, Costa DC. The use of maximum-intensity projections and deep learning adds value to the fully automatic segmentation of lesions avid for [18F]FDG and [68Ga]Ga-PSMA in PET\/CT. J Nuclear Med Soc Nuclear Med. 2025;66:795\u2013801. https:\/\/doi.org\/10.2967\/jnumed.124.269067.","journal-title":"J Nuclear Med Soc Nuclear Med"},{"key":"2066_CR54","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/RLU.0000000000005685","volume":"50","author":"Y Salimi","year":"2025","unstructured":"Salimi Y, Mansouri Z, Shiri I, Mainta I, Zaidi H. Deep learning\u2013powered CT-less multitracer organ segmentation from PET images: a solution for unreliable CT segmentation in PET\/CT imaging. Clin Nucl Med. 2025;50:289. https:\/\/doi.org\/10.1097\/RLU.0000000000005685.","journal-title":"Clin Nucl Med"},{"key":"2066_CR55","doi-asserted-by":"publisher","first-page":"3004","DOI":"10.1007\/s00259-025-07156-8","volume":"52","author":"H Wang","year":"2025","unstructured":"Wang H, Qiao X, Ding W, Chen G, Miao Y, Guo R, et al. Robust and generalizable artificial intelligence for multi-organ segmentation in ultra-low-dose total-body PET imaging: a multi-center and cross-tracer study. Eur J Nucl Med Mol Imaging. 2025;52:3004\u201318. https:\/\/doi.org\/10.1007\/s00259-025-07156-8.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2066_CR56","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3390\/tomography7030027","volume":"7","author":"A Erle","year":"2021","unstructured":"Erle A, Moazemi S, L\u00fctje S, Essler M, Schultz T, Bundschuh RA. Evaluating a machine learning tool for the classification of pathological uptake in whole-body PSMA-PET-CT scans. Tomography. 2021;7:301\u201312. https:\/\/doi.org\/10.3390\/tomography7030027.","journal-title":"Tomography"},{"key":"2066_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/s13550-022-00948-1","volume":"12","author":"KH Leung","year":"2022","unstructured":"Leung KH, Rowe SP, Leal JP, Ashrafinia S, Sadaghiani MS, Chung HW, et al. Deep learning and radiomics framework for PSMA-RADS classification of prostate cancer on PSMA PET. EJNMMI Res. 2022;12:76. https:\/\/doi.org\/10.1186\/s13550-022-00948-1.","journal-title":"EJNMMI Res"},{"key":"2066_CR58","doi-asserted-by":"publisher","first-page":"3412","DOI":"10.1007\/s00259-022-05806-9","volume":"49","author":"E Tr\u00e4g\u00e5rdh","year":"2022","unstructured":"Tr\u00e4g\u00e5rdh E, Enqvist O, Ul\u00e9n J, Hvittfeldt E, Garpered S, Belal SL, et al. Freely available artificial intelligence for pelvic lymph node metastases in PSMA PET-CT that performs on par with nuclear medicine physicians. Eur J Nucl Med Mol Imaging. 2022;49:3412\u20138. https:\/\/doi.org\/10.1007\/s00259-022-05806-9.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2066_CR59","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1007\/s00259-025-07085-6","volume":"52","author":"M Bauckneht","year":"2025","unstructured":"Bauckneht M, Pasini G, Di Raimondo T, Russo G, Raffa S, Donegani MI, et al. [18F]PSMA-1007 PET\/CT-based radiomics may help enhance the interpretation of bone focal uptakes in hormone-sensitive prostate cancer patients. Eur J Nucl Med Mol Imaging. 2025;52:2076\u201386. https:\/\/doi.org\/10.1007\/s00259-025-07085-6.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2066_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11010010","volume":"11","author":"V Fiorentino","year":"2020","unstructured":"Fiorentino V, Martini M, Dell\u2019Aquila M, Musarra T, Orticelli E, Larocca LM, et al. Histopathological ratios to predict gleason score agreement between biopsy and radical prostatectomy. Diagnostics (Basel). 2020;11:10. https:\/\/doi.org\/10.3390\/diagnostics11010010.","journal-title":"Diagnostics (Basel)"},{"key":"2066_CR61","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1007\/s00259-020-04971-z","volume":"48","author":"MCF Cysouw","year":"2021","unstructured":"Cysouw MCF, Jansen BHE, van de Brug T, Oprea-Lager DE, Pfaehler E, de Vries BM, et al. Machine learning-based analysis of [18F]DCFPyL PET radiomics for risk stratification in primary prostate cancer. Eur J Nucl Med Mol Imaging. 2021;48:340\u20139. https:\/\/doi.org\/10.1007\/s00259-020-04971-z.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2066_CR62","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s00259-021-05430-z","volume":"49","author":"EL Solari","year":"2022","unstructured":"Solari EL, Gafita A, Schachoff S, Bogdanovi\u0107 B, Villagr\u00e1n Asiares A, Amiel T, et al. The added value of PSMA PET\/MR radiomics for prostate cancer staging. Eur J Nucl Med Mol Imaging. 2022;49:527\u201338. https:\/\/doi.org\/10.1007\/s00259-021-05430-z.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2066_CR63","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1007\/s00259-025-07099-0","volume":"52","author":"C Miao","year":"2025","unstructured":"Miao C, Yao F, Fang J, Tong Y, Lin H, Lu C, et al. Exploring the role of multimodal [18F]F-PSMA-1007 PET\/CT and multiparametric MRI data in predicting ISUP grading of primary prostate cancer. Eur J Nucl Med Mol Imaging. 2025;52:2087\u201395. https:\/\/doi.org\/10.1007\/s00259-025-07099-0.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2066_CR64","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1007\/s11547-022-01541-1","volume":"127","author":"F Yao","year":"2022","unstructured":"Yao F, Bian S, Zhu D, Yuan Y, Pan K, Pan Z, et al. Machine learning-based radiomics for multiple primary prostate cancer biological characteristics prediction with 18F-PSMA-1007 PET: comparison among different volume segmentation thresholds. Radiol Med. 2022;127:1170\u20138. https:\/\/doi.org\/10.1007\/s11547-022-01541-1.","journal-title":"Radiol Med"},{"key":"2066_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2024.109249","volume":"183","author":"L Luo","year":"2024","unstructured":"Luo L, Wang X, Xie H, Liang H, Gao J, Li Y, et al. Role of [18F]-PSMA-1007 PET radiomics for seminal vesicle invasion prediction in primary prostate cancer. Comput Biol Med. 2024;183:109249. https:\/\/doi.org\/10.1016\/j.compbiomed.2024.109249.","journal-title":"Comput Biol Med"},{"key":"2066_CR66","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.1007\/s00259-025-07134-0","volume":"52","author":"H Lin","year":"2025","unstructured":"Lin H, Yao F, Yi X, Yuan Y, Xu J, Chen L, et al. Prediction of adverse pathology in prostate cancer using a multimodal deep learning approach based on [18F]PSMA-1007 PET\/CT and multiparametric MRI. Eur J Nucl Med Mol Imaging. 2025;52:2814\u201325. https:\/\/doi.org\/10.1007\/s00259-025-07134-0.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2066_CR67","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1007\/s00259-024-07065-2","volume":"52","author":"Q Ma","year":"2025","unstructured":"Ma Q, Chen B, Seifert R, Zhou R, Xiao L, Yang J, et al. PSMA PET\/CT based multimodal deep learning model for accurate prediction of pelvic lymph-node metastases in prostate cancer patients identified as candidates for extended pelvic lymph node dissection by preoperative nomograms. Eur J Nucl Med Mol Imaging. 2025;52:2063\u201375. https:\/\/doi.org\/10.1007\/s00259-024-07065-2.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2066_CR68","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/S1470-2045(21)00274-6","volume":"22","author":"A Gafita","year":"2021","unstructured":"Gafita A, Calais J, Grogan TR, Hadaschik B, Wang H, Weber M, et al. Nomograms to predict outcomes after 177Lu-PSMA therapy in men with metastatic castration-resistant prostate cancer: an international, multicentre, retrospective study. Lancet Oncol. 2021;22:1115\u201325. https:\/\/doi.org\/10.1016\/S1470-2045(21)00274-6.","journal-title":"Lancet Oncol"},{"key":"2066_CR69","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1007\/s00259-024-06734-6","volume":"51","author":"T Li","year":"2024","unstructured":"Li T, Xu M, Yang S, Wang G, Liu Y, Liu K, et al. Development and validation of [18 F]-PSMA-1007 PET-based radiomics model to predict biochemical recurrence-free survival following radical prostatectomy. Eur J Nucl Med Mol Imaging. 2024;51:2806\u201318. https:\/\/doi.org\/10.1007\/s00259-024-06734-6.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2066_CR70","doi-asserted-by":"publisher","first-page":"3176188","DOI":"10.21037\/qims-24-2162","volume":"15","author":"Y Yuan","year":"2025","unstructured":"Yuan Y, Hong W, Yao F, Bian S, Lin H, Pan K, et al. Multimodal radiomics based on fluorine-18 prostate-specific membrane antigen positron emission tomography and multiparametric magnetic resonance imaging in predicting persistent prostate-specific antigen after radical prostatectomy. Quant Imag Med Surg. 2025;15:3176188\u20133173188. https:\/\/doi.org\/10.21037\/qims-24-2162.","journal-title":"Quant Imag Med Surg"},{"key":"2066_CR71","doi-asserted-by":"publisher","first-page":"3747","DOI":"10.1007\/s00261-024-04421-6","volume":"49","author":"S Bian","year":"2024","unstructured":"Bian S, Hong W, Su X, Yao F, Yuan Y, Zhang Y, et al. A dynamic online nomogram predicting prostate cancer short-term prognosis based on 18F-PSMA-1007 PET\/CT of periprostatic adipose tissue: a multicenter study. Abdom Radiol. 2024;49:3747\u201357. https:\/\/doi.org\/10.1007\/s00261-024-04421-6.","journal-title":"Abdom Radiol"},{"key":"2066_CR72","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1056\/NEJMoa2107322","volume":"385","author":"O Sartor","year":"2021","unstructured":"Sartor O, de Bono J, Chi KN, Fizazi K, Herrmann K, Rahbar K, et al. Lutetium-177-PSMA-617 for metastatic castration-resistant prostate cancer. N Engl J Med. 2021;385:1091\u2013103. https:\/\/doi.org\/10.1056\/NEJMoa2107322.","journal-title":"N Engl J Med"},{"key":"2066_CR73","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1007\/s00259-015-3186-3","volume":"42","author":"A Pfestroff","year":"2015","unstructured":"Pfestroff A, Luster M, Jilg CA, Olbert PJ, Ohlmann CH, Lassmann M, et al. Current status and future perspectives of PSMA-targeted therapy in Europe: opportunity knocks. Eur J Nucl Med Mol Imaging. 2015;42:1971\u20135. https:\/\/doi.org\/10.1007\/s00259-015-3186-3.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2066_CR74","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1159\/000541628","volume":"109","author":"O B\u00fclb\u00fcl","year":"2025","unstructured":"B\u00fclb\u00fcl O, Nak D, G\u00f6ksel S. Prediction of lesion-based treatment response after two cycles of Lu-177 prostate specific membrane antigen treatment in metastatic castration-resistant prostate cancer using machine learning. Urol Int. 2025;109:128\u201334. https:\/\/doi.org\/10.1159\/000541628.","journal-title":"Urol Int"},{"key":"2066_CR75","doi-asserted-by":"publisher","DOI":"10.3389\/fnume.2023.1234853","volume":"3","author":"R Gutsche","year":"2023","unstructured":"Gutsche R, G\u00fclm\u00fcs G, Mottaghy FM, G\u00e4rtner F, Essler M, von Mallek D, et al. Multicentric 68Ga-PSMA PET radiomics for treatment response assessment of 177Lu-PSMA-617 radioligand therapy in patients with metastatic castration-resistant prostate cancer. Front Nucl Med. 2023;3:1234853. https:\/\/doi.org\/10.3389\/fnume.2023.1234853.","journal-title":"Front Nucl Med"},{"key":"2066_CR76","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s13246-024-01516-8","volume":"48","author":"K Molin","year":"2025","unstructured":"Molin K, Barry N, Gill S, Hassan GM, Francis RJ, Ong JSL, et al. Evaluating the prognostic value of radiomics and clinical features in metastatic prostate cancer using [68Ga]Ga-PSMA-11 PET\/CT. Phys Eng Sci Med. 2025;48:329\u201341. https:\/\/doi.org\/10.1007\/s13246-024-01516-8.","journal-title":"Phys Eng Sci Med"},{"key":"2066_CR77","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1056\/NEJMc2116647","volume":"385","author":"O Sartor","year":"2021","unstructured":"Sartor O, Morris MJ, Kraus BJ. Lutetium-177-PSMA-617 for Prostate Cancer. Reply N Engl J Med. 2021;385:2495\u20136. https:\/\/doi.org\/10.1056\/NEJMc2116647.","journal-title":"Reply N Engl J Med"},{"key":"2066_CR78","doi-asserted-by":"publisher","first-page":"477","DOI":"10.2967\/jnumed.108.056036","volume":"50","author":"WE Bolch","year":"2009","unstructured":"Bolch WE, Eckerman KF, Sgouros G, Thomas SR. MIRD pamphlet No. 21: a generalized schema for radiopharmaceutical dosimetry--standardization of nomenclature. J Nucl Med. 2009;50:477\u201384. https:\/\/doi.org\/10.2967\/jnumed.108.056036.","journal-title":"J Nucl Med"},{"key":"2066_CR79","doi-asserted-by":"publisher","first-page":"4064","DOI":"10.1007\/s00259-022-05883-w","volume":"49","author":"S Xue","year":"2022","unstructured":"Xue S, Gafita A, Dong C, Zhao Y, Tetteh G, Menze BH, et al. Application of machine learning to pretherapeutically estimate dosimetry in men with advanced prostate cancer treated with 177Lu-PSMA I&T therapy. Eur J Nucl Med Mol Imaging. 2022;49:4064\u201372. https:\/\/doi.org\/10.1007\/s00259-022-05883-w.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2066_CR80","doi-asserted-by":"publisher","first-page":"3450","DOI":"10.1007\/s00259-024-06737-3","volume":"51","author":"S Xue","year":"2024","unstructured":"Xue S, Gafita A, Zhao Y, Mercolli L, Cheng F, Rauscher I, et al. Pre-therapy PET-based voxel-wise dosimetry prediction by characterizing intra-organ heterogeneity in PSMA-directed radiopharmaceutical theranostics. Eur J Nucl Med Mol Imaging. 2024;51:3450\u201360. https:\/\/doi.org\/10.1007\/s00259-024-06737-3.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2066_CR81","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1007\/s00259-022-05727-7","volume":"49","author":"K Sj\u00f6green Gleisner","year":"2022","unstructured":"Sj\u00f6green Gleisner K, Chouin N, Gabina PM, Cicone F, Gnesin S, Stokke C, et al. EANM dosimetry committee recommendations for dosimetry of 177Lu-labelled somatostatin-receptor- and PSMA-targeting ligands. Eur J Nucl Med Mol Imaging. 2022;49:1778\u2013809. https:\/\/doi.org\/10.1007\/s00259-022-05727-7.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2066_CR82","doi-asserted-by":"publisher","first-page":"778","DOI":"10.2967\/jnumed.124.268175","volume":"66","author":"CV Gomes","year":"2025","unstructured":"Gomes CV, Chen Y, Rauscher I, Xue S, Gafita A, Hu J, et al. Characterization of effective half-life for instant single-time-point dosimetry using machine learning. J Nuclear Med Soc Nuclear Med. 2025;66:778\u201384. https:\/\/doi.org\/10.2967\/jnumed.124.268175.","journal-title":"J Nuclear Med. Soc Nuclear Med"},{"key":"2066_CR83","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1007\/s00259-023-06118-2","volume":"50","author":"H Xu","year":"2023","unstructured":"Xu H, Abdallah N, Marion J-M, Chauvet P, Tauber C, Carlier T, et al. Radiomics prognostic analysis of PET\/CT images in a multicenter head and neck cancer cohort: investigating ComBat strategies, sub-volume characterization, and automatic segmentation. Eur J Nucl Med Mol Imaging. 2023;50:1720\u201334. https:\/\/doi.org\/10.1007\/s00259-023-06118-2.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2066_CR84","doi-asserted-by":"publisher","first-page":"3432","DOI":"10.1007\/s00259-021-05303-5","volume":"48","author":"M Ferreira","year":"2021","unstructured":"Ferreira M, Lovinfosse P, Hermesse J, Decuypere M, Rousseau C, Lucia F, et al. [18F]FDG PET radiomics to predict disease-free survival in cervical cancer: a multi-scanner\/center study with external validation. Eur J Nucl Med Mol Imaging. 2021;48:3432\u201343. https:\/\/doi.org\/10.1007\/s00259-021-05303-5.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2066_CR85","doi-asserted-by":"publisher","first-page":"2548","DOI":"10.1007\/s00259-023-06187-3","volume":"50","author":"S Ghezzo","year":"2023","unstructured":"Ghezzo S, Mapelli P, Bezzi C, Samanes Gajate AM, Brembilla G, Gotuzzo I, et al. Role of [68Ga]Ga-PSMA-11 PET radiomics to predict post-surgical ISUP grade in primary prostate cancer. Eur J Nucl Med Mol Imaging. 2023;50:2548\u201360. https:\/\/doi.org\/10.1007\/s00259-023-06187-3.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2066_CR86","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.241613","volume":"314","author":"T Akinci D\u2019Antonoli","year":"2025","unstructured":"Akinci D\u2019Antonoli T, Berger LK, Indrakanti AK, Vishwanathan N, Weiss J, Jung M, et al. Totalsegmentator MRI: robust sequence-independent segmentation of multiple anatomic structures in MRI. Radiology. 2025;314:e241613. https:\/\/doi.org\/10.1148\/radiol.241613.","journal-title":"Radiology"},{"key":"2066_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.media.2023.102918","volume":"89","author":"MA Mazurowski","year":"2023","unstructured":"Mazurowski MA, Dong H, Gu H, Yang J, Konz N, Zhang Y. Segment anything model for medical image analysis: an experimental study. Med Image Anal. 2023;89:102918. https:\/\/doi.org\/10.1016\/j.media.2023.102918.","journal-title":"Med Image Anal"},{"key":"2066_CR88","doi-asserted-by":"publisher","DOI":"10.2196\/42822","volume":"25","author":"AA Sinaci","year":"2023","unstructured":"Sinaci AA, Gencturk M, Teoman HA, Laleci Erturkmen GB, Alvarez-Romero C, Martinez-Garcia A, et al. A data transformation methodology to create findable, accessible, interoperable, and reusable health data: software design, development, and evaluation study. J Med Internet Res. 2023;25:e42822. https:\/\/doi.org\/10.2196\/42822.","journal-title":"J Med Internet Res"},{"key":"2066_CR89","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1109\/TIP.2024.3361689","volume":"33","author":"N Wang","year":"2024","unstructured":"Wang N, Qi L, Guo J, Shi Y, Gao Y. Learning generalizable models via disentangling spurious and enhancing potential correlations. IEEE Trans Image Process. 2024;33:1627\u201342. https:\/\/doi.org\/10.1109\/TIP.2024.3361689.","journal-title":"IEEE Trans Image Process"},{"key":"2066_CR90","doi-asserted-by":"publisher","first-page":"8944","DOI":"10.1038\/s41598-019-45415-5","volume":"9","author":"T Iizuka","year":"2019","unstructured":"Iizuka T, Fukasawa M, Kameyama M. Deep-learning-based imaging-classification identified cingulate island sign in dementia with Lewy bodies. Sci Rep. 2019;9:8944. https:\/\/doi.org\/10.1038\/s41598-019-45415-5.","journal-title":"Sci Rep"},{"key":"2066_CR91","doi-asserted-by":"publisher","DOI":"10.1148\/ryai.220187","volume":"5","author":"A Wollek","year":"2022","unstructured":"Wollek A, Graf R, \u010ce\u010datka S, Fink N, Willem T, Sabel BO, et al. Attention-based saliency maps improve interpretability of pneumothorax classification. Radiol Artif Intell. 2022;5:e220187. https:\/\/doi.org\/10.1148\/ryai.220187.","journal-title":"Radiol Artif Intell"},{"key":"2066_CR92","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1109\/TMI.2014.2377694","volume":"34","author":"BH Menze","year":"2015","unstructured":"Menze BH, Jakab A, Bauer S, Kalpathy-Cramer J, Farahani K, Kirby J, et al. The Multimodal Brain Tumor Image Segmentation Benchmark (BRATS). IEEE Trans Med Imaging. 2015;34:1993\u20132024. https:\/\/doi.org\/10.1109\/TMI.2014.2377694.","journal-title":"IEEE Trans Med Imaging"},{"key":"2066_CR93","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.3174\/ajnr.A5667","volume":"39","author":"P Chang","year":"2018","unstructured":"Chang P, Grinband J, Weinberg BD, Bardis M, Khy M, Cadena G, et al. Deep-learning convolutional neural networks accurately classify genetic mutations in gliomas. AJNR Am J Neuroradiol. 2018;39:1201\u20137. https:\/\/doi.org\/10.3174\/ajnr.A5667.","journal-title":"AJNR Am J Neuroradiol"},{"key":"2066_CR94","doi-asserted-by":"publisher","first-page":"3643","DOI":"10.1007\/s00259-021-05371-7","volume":"48","author":"M Kirienko","year":"2021","unstructured":"Kirienko M, Sollini M, Corbetta M, Voulaz E, Gozzi N, Interlenghi M, et al. Radiomics and gene expression profile to characterise the disease and predict outcome in patients with lung cancer. Eur J Nucl Med Mol Imaging. 2021;48:3643\u201355. https:\/\/doi.org\/10.1007\/s00259-021-05371-7.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2066_CR95","doi-asserted-by":"publisher","first-page":"233","DOI":"10.2967\/jnumed.120.261863","volume":"63","author":"N Nickols","year":"2022","unstructured":"Nickols N, Anand A, Johnsson K, Brynolfsson J, Borreli P, Parikh N, et al. aPROMISE: a novel automated PROMISE platform to standardize evaluation of tumor burden in 18F-DCFPyL images of veterans with prostate cancer. J Nucl Med. 2022;63:233\u20139. https:\/\/doi.org\/10.2967\/jnumed.120.261863.","journal-title":"J Nucl Med"},{"key":"2066_CR96","doi-asserted-by":"publisher","DOI":"10.2196\/55833","volume":"3","author":"V Gupta","year":"2024","unstructured":"Gupta V, Erdal B, Ramirez C, Floca R, Genereaux B, Bryson S, et al. Current state of community-driven radiological AI deployment in medical imaging. JMIR AI. 2024;3:e55833. https:\/\/doi.org\/10.2196\/55833.","journal-title":"JMIR AI"},{"key":"2066_CR97","doi-asserted-by":"publisher","first-page":"3206","DOI":"10.1109\/JBHI.2024.3375894","volume":"28","author":"J Mu","year":"2024","unstructured":"Mu J, Kadoch M, Yuan T, Lv W, Liu Q, Li B. Explainable federated medical image analysis through causal learning and blockchain. IEEE J Biomed Health Inform. 2024;28:3206\u201318. https:\/\/doi.org\/10.1109\/JBHI.2024.3375894.","journal-title":"IEEE J Biomed Health Inform"},{"key":"2066_CR98","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41591-018-0300-7","volume":"25","author":"EJ Topol","year":"2019","unstructured":"Topol EJ. High-performance medicine: the convergence of human and artificial intelligence. Nat Med Nature Publishing Group. 2019;25:44\u201356. https:\/\/doi.org\/10.1038\/s41591-018-0300-7.","journal-title":"Nat Med Nature Publishing Group"},{"key":"2066_CR99","doi-asserted-by":"publisher","unstructured":"Cook GJR, Alberts IL, Wagner T, Fischer BM, Nazir MS, Lilburn D. The impact of long axial field of view (LAFOV) PET on oncologic imaging. European Journal of Radiology [Internet]. Elsevier; 2025 [cited 2025 June 16];183. https:\/\/doi.org\/10.1016\/j.ejrad.2024.111873","DOI":"10.1016\/j.ejrad.2024.111873"},{"key":"2066_CR100","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1016\/j.ccell.2024.10.015","volume":"42","author":"G Seed","year":"2024","unstructured":"Seed G, Beije N, Yuan W, Bertan C, Goodall J, Lundberg A, et al. Elucidating acquired PARP inhibitor resistance in advanced prostate cancer. Cancer Cell. 2024;42:2113-2123.e4. https:\/\/doi.org\/10.1016\/j.ccell.2024.10.015.","journal-title":"Cancer Cell"},{"key":"2066_CR101","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14051118","volume":"14","author":"F Lorenzin","year":"2022","unstructured":"Lorenzin F, Demichelis F. Past, current, and future strategies to target ERG fusion-positive prostate cancer. Cancers (Basel). 2022;14:1118. https:\/\/doi.org\/10.3390\/cancers14051118.","journal-title":"Cancers (Basel)"},{"key":"2066_CR102","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41388-023-02875-4","volume":"43","author":"KA Miller","year":"2024","unstructured":"Miller KA, Degan S, Wang Y, Cohen J, Ku SY, Goodrich DW, et al. PTEN-regulated PI3K-p110 and AKT isoform plasticity controls metastatic prostate cancer progression. Oncogene. 2024;43:22\u201334. https:\/\/doi.org\/10.1038\/s41388-023-02875-4.","journal-title":"Oncogene"},{"key":"2066_CR103","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1129140","volume":"13","author":"KJ Miller","year":"2023","unstructured":"Miller KJ, Henry I, Maylin Z, Smith C, Arunachalam E, Pandha H, et al. A compendium of androgen receptor variant 7 target genes and their role in castration resistant prostate cancer. Front Oncol. 2023;13:1129140. https:\/\/doi.org\/10.3389\/fonc.2023.1129140.","journal-title":"Front Oncol"},{"key":"2066_CR104","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01938-6","volume":"9","author":"X Gu","year":"2024","unstructured":"Gu X, Wei S, Lv X. Circulating tumor cells: from new biological insights to clinical practice. Signal Transduct Target Ther. 2024;9:226. https:\/\/doi.org\/10.1038\/s41392-024-01938-6.","journal-title":"Signal Transduct Target Ther"},{"key":"2066_CR105","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1158\/1078-0432.CCR-23-1043","volume":"29","author":"O Sartor","year":"2023","unstructured":"Sartor O. Circulating tumor DNA biomarkers for response assessment in prostate cancer. Clin Cancer Res. 2023;29:2745\u20137. https:\/\/doi.org\/10.1158\/1078-0432.CCR-23-1043.","journal-title":"Clin Cancer Res"},{"key":"2066_CR106","doi-asserted-by":"publisher","first-page":"69","DOI":"10.2967\/jnumed.120.262250","volume":"63","author":"R Chen","year":"2022","unstructured":"Chen R, Wang Y, Zhu Y, Shi Y, Xu L, Huang G, et al. The added value of 18F-FDG PET\/CT compared with 68Ga-PSMA PET\/CT in patients with castration-resistant prostate cancer. J Nucl Med. 2022;63:69\u201375. https:\/\/doi.org\/10.2967\/jnumed.120.262250.","journal-title":"J Nucl Med"},{"key":"2066_CR107","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101463","volume":"5","author":"M Salehjahromi","year":"2024","unstructured":"Salehjahromi M, Karpinets TV, Sujit SJ, Qayati M, Chen P, Aminu M, et al. Synthetic PET from CT improves diagnosis and prognosis for lung cancer: proof of concept. Cell Rep Med. 2024;5:101463. https:\/\/doi.org\/10.1016\/j.xcrm.2024.101463.","journal-title":"Cell Rep Med"},{"key":"2066_CR108","doi-asserted-by":"publisher","DOI":"10.1016\/j.media.2023.103046","volume":"92","author":"S Dayarathna","year":"2024","unstructured":"Dayarathna S, Islam KT, Uribe S, Yang G, Hayat M, Chen Z. Deep learning based synthesis of MRI, CT and PET: review and analysis. Med Image Anal. 2024;92:103046. https:\/\/doi.org\/10.1016\/j.media.2023.103046.","journal-title":"Med Image Anal"},{"key":"2066_CR109","doi-asserted-by":"publisher","DOI":"10.1186\/s13550-022-00936-5","volume":"12","author":"S Zang","year":"2022","unstructured":"Zang S, Ai S, Yang R, Zhang P, Wu W, Zhao Z, et al. Development and validation of 68Ga-PSMA-11 PET\/CT-based radiomics model to detect primary prostate cancer. EJNMMI Res. 2022;12:63. https:\/\/doi.org\/10.1186\/s13550-022-00936-5.","journal-title":"EJNMMI Res"},{"key":"2066_CR110","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s00259-022-05927-1","volume":"50","author":"J Kendrick","year":"2022","unstructured":"Kendrick J, Francis RJ, Hassan GM, Rowshanfarzad P, Ong JSL, Ebert MA. Fully automatic prognostic biomarker extraction from metastatic prostate lesion segmentations in whole-body [68Ga]Ga-PSMA-11 PET\/CT images. Eur J Nucl Med Mol Imaging. 2022;50:67\u201379. https:\/\/doi.org\/10.1007\/s00259-022-05927-1.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2066_CR111","doi-asserted-by":"publisher","first-page":"643","DOI":"10.2967\/jnumed.123.267048","volume":"65","author":"KH Leung","year":"2024","unstructured":"Leung KH, Rowe SP, Sadaghiani MS, Leal JP, Mena E, Choyke PL, et al. Deep semisupervised transfer learning for fully automated whole-body tumor quantification and prognosis of cancer on PET\/CT. J Nuclear Med Soc Nuclear Med. 2024;65:643\u201350. https:\/\/doi.org\/10.2967\/jnumed.123.267048.","journal-title":"J Nuclear Med. Soc Nuclear Med"},{"key":"2066_CR112","doi-asserted-by":"publisher","first-page":"25929","DOI":"10.1038\/s41598-024-76288-y","volume":"14","author":"SL B\u00fcrkle","year":"2024","unstructured":"B\u00fcrkle SL, Kuhn D, Fechter T, Radicioni G, Hartong N, Freitag MT, et al. A student trained convolutional neural network competing with a commercial AI software and experts in organ at risk segmentation. Sci Rep. 2024;14:25929. https:\/\/doi.org\/10.1038\/s41598-024-76288-y.","journal-title":"Sci Rep"},{"key":"2066_CR113","doi-asserted-by":"publisher","first-page":"622","DOI":"10.3390\/diagnostics10090622","volume":"10","author":"S Moazemi","year":"2020","unstructured":"Moazemi S, Khurshid Z, Erle A, L\u00fctje S, Essler M, Schultz T, et al. Machine learning facilitates hotspot classification in PSMA-PET\/CT with nuclear medicine specialist accuracy. Diagnostics. 2020;10:622. https:\/\/doi.org\/10.3390\/diagnostics10090622.","journal-title":"Diagnostics"},{"key":"2066_CR114","doi-asserted-by":"publisher","first-page":"5680","DOI":"10.3390\/cancers14225680","volume":"14","author":"S Mattoni","year":"2022","unstructured":"Mattoni S, Farolfi A, Formaggio F, Bruno G, Caroli P, Cerci JJ, et al. PSMA PET for the evaluation of liver metastases in castration-resistant prostate cancer patients: a multicenter retrospective study. Cancers. 2022;14:5680. https:\/\/doi.org\/10.3390\/cancers14225680.","journal-title":"Cancers"},{"key":"2066_CR115","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1007\/s00259-020-05140-y","volume":"48","author":"L Papp","year":"2021","unstructured":"Papp L, Spielvogel CP, Grubm\u00fcller B, Grahovac M, Krajnc D, Ecsedi B, et al. Supervised machine learning enables non-invasive lesion characterization in primary prostate cancer with [68Ga]Ga-PSMA-11 PET\/MRI. Eur J Nucl Med Mol Imaging. 2021;48:1795\u2013805. https:\/\/doi.org\/10.1007\/s00259-020-05140-y.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2066_CR116","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s00259-021-05473-2","volume":"49","author":"N Capobianco","year":"2022","unstructured":"Capobianco N, Sibille L, Chantadisai M, Gafita A, Langbein T, Platsch G, et al. Whole-body uptake classification and prostate cancer staging in 68Ga-PSMA-11 PET\/CT using dual-tracer learning. Eur J Nucl Med Mol Imaging. 2022;49:517\u201326. https:\/\/doi.org\/10.1007\/s00259-021-05473-2.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2066_CR117","doi-asserted-by":"publisher","unstructured":"Dutta A, Chan J, Haworth A, Dubowitz DJ, Kneebone A, Reynolds HM. Robustness of magnetic resonance imaging and positron emission tomography radiomic features in prostate cancer: Impact on recurrence prediction after radiation therapy. Physics and Imaging in Radiation Oncology [Internet]. Elsevier; 2024 [cited 2025 June 8];29. https:\/\/doi.org\/10.1016\/j.phro.2023.100530","DOI":"10.1016\/j.phro.2023.100530"},{"key":"2066_CR118","doi-asserted-by":"publisher","first-page":"3849","DOI":"10.3390\/cancers13153849","volume":"13","author":"W Roll","year":"2021","unstructured":"Roll W, Schindler P, Masthoff M, Seifert R, Schlack K, B\u00f6gemann M, et al. Evaluation of 68Ga-PSMA-11 PET-MRI in patients with advanced prostate cancer receiving 177Lu-PSMA-617 therapy: a radiomics analysis. Cancers. 2021;13:3849. https:\/\/doi.org\/10.3390\/cancers13153849.","journal-title":"Cancers"}],"container-title":["Japanese Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11604-026-02066-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11604-026-02066-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11604-026-02066-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T06:21:25Z","timestamp":1787984485000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11604-026-02066-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,29]]},"references-count":118,"alternative-id":["2066"],"URL":"https:\/\/doi.org\/10.1007\/s11604-026-02066-7","relation":{},"ISSN":["1867-1071","1867-108X"],"issn-type":[{"value":"1867-1071","type":"print"},{"value":"1867-108X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,29]]},"assertion":[{"value":"6 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}]}}